Weight Loss Drugs Linked to Men's Hair Loss
A new study from NYU Langone Health suggests that men with a genetic predisposition for hair loss may face an increased risk when using GLP-1 receptor agonist weight loss drugs like Ozempic. Researchers found a link between the GLP1R gene and androgenetic alopecia, independent of other factors like weight loss or insulin resistance.
Why it matters
As GLP-1 medications become widely prescribed for obesity and diabetes, understanding potential side effects is critical for patient safety and informed medical decision-making.
Men already at risk genetically for the most common form of hair loss have a 7 percent added risk of losing their hair if they use drugs like Ozempic, Wegovy, and Zepbound for type 2 diabetes and obesity, a new study shows.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in